MariMed (OTCMKTS:MRMD) Posts Earnings Results, Hits Estimates

MariMed (OTCMKTS:MRMDGet Free Report) released its earnings results on Wednesday. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01), Zacks reports. MariMed had a negative return on equity of 2.75% and a negative net margin of 10.97%.

MariMed Price Performance

Shares of MRMD stock traded up $0.00 during mid-day trading on Wednesday, hitting $0.12. The company had a trading volume of 937,712 shares, compared to its average volume of 404,236. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.55 and a quick ratio of 0.73. The stock’s 50 day moving average price is $0.12 and its 200-day moving average price is $0.15. MariMed has a 52-week low of $0.11 and a 52-week high of $0.34. The company has a market capitalization of $43.87 million, a P/E ratio of -2.88 and a beta of 2.69.

About MariMed

(Get Free Report)

MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.

Featured Articles

Earnings History for MariMed (OTCMKTS:MRMD)

Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.